Related Experiment Videos
Causes of hemodialysis access failure
1Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Summary
Complications of hemodialysis access, including thrombosis and infection, significantly impact patients undergoing renal replacement therapy. Understanding these issues is crucial for developing effective interventions and improving patient outcomes.
Area of Science:
- Nephrology
- Vascular Surgery
- Biomedical Engineering
Background:
- Complications of hemodialysis access are a major challenge for patients receiving renal replacement therapy.
- Native arteriovenous fistulas are preferred for their longevity and low complication rates, but not all patients are candidates.
- Expanded polytetrafluoroethylene (ePTFE) grafts are used when fistulas are not feasible.
Purpose of the Study:
- To recognize the causes of hemodialysis access loss.
- To identify factors contributing to early and late complications.
- To explore potential mechanisms disrupting the balance of hemostasis within arteriovenous conduits.
Main Methods:
- Review of existing literature on hemodialysis access complications.
- Analysis of causes for failure in native arteriovenous fistulas and ePTFE grafts.
- Discussion of thrombosis and infection as primary causes of access morbidity.
Main Results:
- Thrombosis is the leading cause of failure for both native fistulas and ePTFE grafts.
- ePTFE grafts are also susceptible to infection, pseudoaneurysms, and hematomas.
- Thrombosis in ePTFE grafts is often linked to stenosis but can also occur in low-flow states, potentially due to disrupted endothelial hemostasis.
- Staphylococcus aureus is a common pathogen in access infections, with no clear consensus on optimal treatment.
Conclusions:
- Effective interventions for hemodialysis access complications require a thorough understanding of their causes.
- Thrombosis and infection represent significant challenges in maintaining functional hemodialysis access.
- Further research is needed to address the complexities of access-related morbidity, particularly concerning infection management.